Unless the tadalafil you received was solubilised it has no greater efficacy that a tablet as you observed. As tadalafil is considered a BCS II drug, solubilisation is critical to improving bioavailability. Nextract has address the issue of tadalafil solubility and drug delivery via non-oral routes. Clinical data is typically closely held and critical to patent applications and therefore not usually release in ASX releases.
Add to My Watchlist
What is My Watchlist?
